GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Clasificación en acciones #3658
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Precio por acción
$27.24
Capitalización bursátil
$4.61B
Cambio (1 día)
-1.10%
Cambio (1 año)
-13.10%
País
IN
Comercio GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Categoría

Healthcare
Historial de desdoblamientos de acciones de GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
La acción GlaxoSmithKline Pharmaceuticals Limited (símbolo: GLAXO) tuvo un total de 1 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 11, 2018.
Una acción GLAXO comprada antes de Sep 11, 2018 equivaldría hoy a 2 acciones GLAXO.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
2018-09-11 2:1 x2 x2
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
4 x15
US
7 x432
US
0 -
US
7 x226
US
2 x10000
CH